 After reading the news excerpt on the fictional breakthrough drug in each of the 5 conditions, participants were surveyed on the safety and efficacy of the drug described in the news excerpt How safe is Zykanta compared to other drugs approved to treat metastatic lung cancer?, How risky is Zykanta compared to other drugs approved to treat metastatic lung cancer?, Has Zykanta been proven to save the lives of patients with metastatic lung cancer, How effective do you think Zykanta is at treating metastatic lung cancer? If a patient with metastatic lung cancer started to take Zykanta, what do you think would happen to their tumor over the next 6 months? and How effective is Zykanta compared to other drugs approved to treat metastatic lung cancer? and the strength of the scientific evidence that the drug helps metastatic lung cancer How strong is the scientific evidence that Zykanta helps patients with metastatic lung cancer? and If you were deciding to take Zykanta, would you feel confident making that decision given your current knowledge of the drug?. We also asked about the likelihood of a symptom that was explicitly stated as a common symptom in the drug description If a patient with metastatic lung cancer started to take Zykanta, how likely is it that they would experience abdominal pain within 6 months? and about their own anticipated behavior with respect to the drug If you were diagnosed with metastatic lung cancer, would you want to take Zykanta? and If a close friend or family member was diagnosed with metastatic lung cancer, would you want them to take Zykanta?. Each response was measured on a 4 or 5-point Likert scale. 